AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,272,890 | -75.2% | 544,720 | -71.9% | 0.02% | -75.8% |
| Q1 2023 | $21,262,104 | +125.4% | 1,939,973 | -11.1% | 0.07% | +106.2% |
| Q4 2022 | $9,431,191 | +130.9% | 2,183,146 | +594.0% | 0.03% | +68.4% |
| Q1 2021 | $4,085,000 | -86.2% | 314,565 | -85.3% | 0.02% | -86.8% |
| Q4 2020 | $29,589,000 | -14.3% | 2,139,461 | -8.7% | 0.14% | -18.6% |
| Q3 2020 | $34,523,000 | -44.7% | 2,343,751 | -39.0% | 0.18% | -56.5% |
| Q2 2020 | $62,461,000 | -7.8% | 3,843,741 | -17.7% | 0.41% | -26.0% |
| Q1 2020 | $67,752,000 | -7.0% | 4,669,343 | +29.9% | 0.55% | +43.6% |
| Q4 2019 | $72,848,000 | +62700.0% | 3,595,633 | +16429.4% | 0.38% | +38200.0% |
| Q3 2019 | $116,000 | -20.0% | 21,753 | -1.5% | 0.00% | 0.0% |
| Q2 2019 | $145,000 | +663.2% | 22,083 | +670.2% | 0.00% | – |
| Q1 2019 | $19,000 | -99.2% | 2,867 | -99.5% | 0.00% | -100.0% |
| Q4 2017 | $2,433,000 | – | 537,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |